Publications by authors named "Frosch A"

Background: Iron deficiency is the most common nutritional deficiency in the world, but iron supplementation can increase risk of opportunistic infections, especially in children living with HIV. We aimed to assess the effect of supplemental iron on haemoglobin concentration in children living with HIV and mild-to-moderate anaemia in Uganda.

Methods: We did a double-blind, randomised, placebo-controlled trial of iron supplementation in children aged 6 months to 12 years living with HIV at two sites (ie, Kampala and Fort Portal, Uganda).

View Article and Find Full Text PDF

Carcinosarcomas are high-grade endometrial cancers which enclose mesenchymal and epithelial differentiated components. The vast majority of these cancers belong to the p53 abnormal molecular subgroup and usually come with an unfavorable prognosis. POLE mutant carcinosarcomas are a rarity and only make up about 5% of this histologic subtype.

View Article and Find Full Text PDF

Malaria, which results from infection with Plasmodium parasites, remains a major public health problem. Although humans do not develop long-lived, sterilizing immunity, protection against symptomatic disease develops after repeated exposure to Plasmodium parasites and correlates with the acquisition of humoral immunity. Despite the established role Abs play in protection from malaria disease, dysregulated inflammation is thought to contribute to the suboptimal immune response to Plasmodium infection.

View Article and Find Full Text PDF
Article Synopsis
  • Prolonged SARS-CoV-2 infections may pose a risk for the development of mutated variants, particularly in immunocompromised individuals, but the specific types of immunosuppressive conditions that increase this risk have not been extensively studied.
  • A study conducted across five US medical centers involved 150 immunocompromised patients to identify factors contributing to extended SARS-CoV-2 infections through regular testing and genetic sequencing.
  • Results showed that patients with B-cell dysfunction and those who had solid organ transplants or HIV had longer durations of infection compared to those with autoimmune conditions, indicating varying risks based on the type of immunosuppression.
View Article and Find Full Text PDF
Article Synopsis
  • The study focused on prolonged SARS-CoV-2 infections in immunocompromised patients, aiming to identify which types of immunosuppression might lead to longer infections and increased viral mutations.
  • Conducted at five hospitals, the research enrolled 150 adults with various immunocompromising conditions and monitored their nasal specimens for changes in viral presence and mutations over several months.
  • Results indicated that while prolonged infections were rare, individuals with infections lasting over 56 days developed unique spike mutations not commonly found in the broader population, highlighting the risk of viral evolution in these patients.
View Article and Find Full Text PDF
Article Synopsis
  • SARS-CoV-2 RNA levels, specifically total nucleocapsid (N) and subgenomic N (sgN), are commonly used indicators of how infectious someone with COVID-19 might be, but the influence of various host factors and virus variants on these levels was uncertain.
  • Researchers analyzed RNA levels in samples from over 3,200 hospitalized COVID-19 patients using RT-qPCR, examining how factors like time of sampling, virus variant, age, and vaccination impacted the RNA viral load.
  • Results indicated that RNA levels varied primarily by the type of SARS-CoV-2 variant and timing of symptom onset, but not based on patient age or vaccination, suggesting that subgenomic RNA measurements may not provide significant additional
View Article and Find Full Text PDF

Background: Coronavirus disease 2019 (COVID-19) vaccine effectiveness (VE) studies are increasingly reporting relative VE (rVE) comparing a primary series plus booster doses with a primary series only. Interpretation of rVE differs from traditional studies measuring absolute VE (aVE) of a vaccine regimen against an unvaccinated referent group. We estimated aVE and rVE against COVID-19 hospitalization in primary-series plus first-booster recipients of COVID-19 vaccines.

View Article and Find Full Text PDF

Background: Test-negative design (TND) studies have produced validated estimates of vaccine effectiveness (VE) for influenza vaccine studies. However, syndrome-negative controls have been proposed for differentiating bias and true estimates in VE evaluations for COVID-19. To understand the use of alternative control groups, we compared characteristics and VE estimates of syndrome-negative and test-negative VE controls.

View Article and Find Full Text PDF
Article Synopsis
  • This study aimed to evaluate how effective COVID-19 vaccines, both with and without booster doses, are at preventing hospital admissions due to the omicron variant in the U.S.
  • Conducted in 18 hospitals, the research involved 4,760 adults diagnosed with respiratory symptoms, half of whom had confirmed COVID-19, allowing for a comparison between vaccinated and unvaccinated individuals based on their COVID-19 vaccine status.
  • Results showed that vaccine effectiveness varied: for immunocompetent patients, receiving a primary series plus two boosters had a 63% effectiveness, one booster had 65%, whereas a primary series alone was only 37% effective against hospitalization due to COVID-19.
View Article and Find Full Text PDF

To compare the effectiveness of a primary COVID-19 vaccine series plus a booster dose with a primary series alone for the prevention of Omicron variant COVID-19 hospitalization. Multicenter observational case-control study using the test-negative design to evaluate vaccine effectiveness (VE). Twenty-one hospitals in the United States (US).

View Article and Find Full Text PDF

COVID-19 mRNA vaccines (BNT162b2 [Pfizer-BioNTech] and mRNA-1273 [Moderna]) are effective at preventing COVID-19-associated hospitalization (1-3). However, how well mRNA vaccines protect against the most severe outcomes of these hospitalizations, including invasive mechanical ventilation (IMV) or death is uncertain. Using a case-control design, mRNA vaccine effectiveness (VE) against COVID-19-associated IMV and in-hospital death was evaluated among adults aged ≥18 years hospitalized at 21 U.

View Article and Find Full Text PDF

We previously identified a Plasmodium falciparum (Pf) protein of unknown function encoded by a single-copy gene, PF3D7_1134300, as a target of antibodies in plasma of Tanzanian children in a whole-proteome differential screen. Here we characterize this protein as a blood-stage antigen that localizes to the surface membranes of both parasitized erythrocytes and merozoites, hence its designation as Pf erythrocyte membrane and merozoite antigen 1 (PfEMMA1). Mouse anti-PfEMMA1 antisera and affinity-purified human anti-PfEMMA1 antibodies inhibited growth of P.

View Article and Find Full Text PDF

Porous structure properties are known to conduct initial and long-term stability of titanium alloy implants. This study aims to assess the histomorphometric effect of a 3-D porosity in Ti-6Al-4V implants (PI) on osseointegration in comparison to solid Ti-6Al-4V implants (SI). The PI was produced in a spaceholder method and sintering and has a pore size of mean 400 µm (50 µm to 500 µm) and mimics human trabecular bone.

View Article and Find Full Text PDF

In the present study, we analyzed the histological characteristics of osseointegration of an open-porous Ti-6Al-4V material that was produced in a space holder method creating a 3-D through-pores trabecular design that mimics the inhomogeneity and size relationships of trabecular bone in macro- as well as microstructure. Pairs of cylindrical implants with a porosity of 49 % and an average pore diameter of 400 µm (PI) or equal sized solid, corundum blasted devices (SI) as reference were bilaterally implanted press fit in the lateral condyles of 16 rabbits. Histological examination was performed after 4 weeks of short-term osseohealing and 12 weeks of mid-term osseoremodeling and we summarized the criteria for sequential osseointegration.

View Article and Find Full Text PDF

To date, COVID-19 has spread to more than 108 million people globally, with a death toll surpassing 2 1/2 million. With the United States Food and Drug Administration (FDA) approval of two highly effective COVID-19 vaccines from Pfizer-BioNtech and Moderna, we now have a novel approach to contain COVID-19 related morbidity and mortality. Chronic pain care has faced unprecedented challenges for patients and providers in this ever-changing climate.

View Article and Find Full Text PDF

Prevalence and levels of antibodies to multiple antigens show promise as tools for estimating malaria exposure. In a highland area of Kenya with unstable transmission, we assessed the presence and levels of antibodies to 12 pre-erythrocytic and blood-stage antigens by multiplex cytometric bead assay or ELISA in 604 individuals in August 2007, with follow-up testing in this cohort in April 2008, April 2009, and May 2010. Four hundred individuals were tested at all four time points.

View Article and Find Full Text PDF

Although CD4 T cell memory is a critical component of adaptive immunity, antigen-specific CD4 T cell recall responses to secondary infection have been inadequately studied. Here we examine the kinetics of the secondary response in an important immunological model, infection with attenuated (Lm). We identify CD4 T cell subsets that preferentially expand during a secondary response and highlight the importance of prime-boost strategies in expanding and maintaining antigen-specific, tissue-resident memory CD4 T cells.

View Article and Find Full Text PDF

Malaria due to Plasmodium falciparum (Pf) may be missed if patients present with symptoms outside of the expected incubation period. We describe two patients who developed Pf malaria more than one year after visiting malaria-endemic countries. Both worked at an international airport, but no source of infection was identified.

View Article and Find Full Text PDF
Article Synopsis
  • Studies show that despite global malaria reduction, cases are increasing in the U.S., particularly among travelers from sub-Saharan Africa, especially VFRs (visiting friends and relatives).
  • The research aimed to identify differences in malaria prevention knowledge, attitudes, and practices between VFRs and other travelers to Africa through a comprehensive survey involving 489 participants.
  • Results indicated that VFRs diagnosed with malaria had more frequent trips to their home country and showed greater concern about malaria risks when they took preventive medications compared to those who did not.
View Article and Find Full Text PDF

A PHP Error was encountered

Severity: 8192

Message: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated

Filename: helpers/my_audit_helper.php

Line Number: 8900

Backtrace:

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 8900
Function: str_replace

File: /var/www/html/application/controllers/Author.php
Line: 786
Function: formatAIDetailSummary

File: /var/www/html/application/controllers/Author.php
Line: 685
Function: pubMedSearchtoAuthorResults_array

File: /var/www/html/application/controllers/Author.php
Line: 122
Function: pubMedAuthorSearch_array

File: /var/www/html/index.php
Line: 316
Function: require_once